A Study of of HOT1030 in Patients With Advanced Solid Tumors

Clinical trial NCT05060263 · UNKNOWN

Trial details

NCT number: NCT05060263
Sponsor: Huabo Biopharm Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2021-03-12
Primary completion: 2023-06-30
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.